Portfolio

GPER G-1 is a drug discovery and development company with the primary goal of advancing pre-clinical development of novel drug candidates that modulate the G-Protein Coupled Estrogen Receptor (GPER). The lead drug candidate is G-1 (EsperaTM), which is a GPER agonist to treat obesity through weight loss, and to reverse diabetes and pre-diabetes.

Osazda Energy provides materials engineering solutions to improve solar cell and solar module reliability with specialized metal matrix composites that have been proven to electrically bridge stress-induced cracks that appear in solar cells over time.

T-Neuro is an Alzheimer’s biomarker and therapeutic company. The company focuses on the T-cell contribution to the pathology of the disease. This T-cell response can be detected in blood as an early diagnostic tool and blocked as a therapeutic avenue.

MNT SmartSolutions is a biotech company that is engineering sustainable, modern “smart” materials, with unique electronic and magnetic properties for the advancement of science and medicine. These novel materials are effective in treating periodontal disease and gingivitis by reaching the bacteria beneath the gum line in a non-invasive and ecofriendly application. The technology also has great potential as a topical anti-bacterial treatment for wounds, abrasions and virtually any application in which antimicrobial action is sought.

MNT SmartSolutions is a biotech company that is engineering sustainable, modern “smart” Enthentica is developing a new hardware and software security systems platform to protect hardware from hackers. A physical unclonable function, or PUF, is a “digital fingerprint” that serves as a unique identity for a semiconductor device such as a microprocessor.

Zocere, Inc. is a New Mexico-based biotech company that is developing novel therapeutics for destructive neurological diseases, including stroke. We have exclusively licensed a patented technology for a derivative of the brain-specific STEP protein, tyrosine phosphatase, developed by Dr. Surojit Paul at the University of New Mexico. Our neuroprotectant can be administered via IV, crosses the blood-brain barrier and may be used in conjunction with clot busing treatments. Our technology is a novel, generation next therapeutic treatment of stroke that shows promise of becom­ing the first injectable neuroprotectant drug in the market.

Lotus Leaf Coatings manufacturers and distributes superhydrophobic and superhydrophillic coatings to either attract or repel moisture depending on the useage.

Dynamic Photonics Inc. is a developer of high-performance, inexpensive transceiver modules for high-speed lightwave communications. With extensive expertise in the design and operation of avalanche photodiodes, high-speed microwave circuits, and communication theory, the company is able to produce innovative solutions to receivers for the 40-giga bit per second optical communication market and beyond.

Ecopesticides International is using a method in which a naturally occuring pesticide is encapsulated in a UV resistant gel. The gel allows for a longer lasting and more effective pesticide. Naturally occurring pesticides (bacteria or fungi) are frequently used, but limited due to their rapid degradation in UV light and high heat. This technology is safer than traditional pesticides, ecofriendly and has already received funding from the Bill and Melinda Gates Foundation.

Aquaculture Solutions, Inc. was created to develop solutions to aquaculture disease. The company is developing technologies for
attenuating infectious disease outbreaks using single-chain antibody fragments (ScFv) and anti-microbial peptides in feed and novel delivery strategies to impart passive immunity to farmed animals of aquaculture. The initial commercial target is shrimp aquaculture, with a focus on White Spot Syndrome Virus (WSSV) and Vibrio infections.